Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and …
Y Inamoto, N Valdés-Sanz, Y Ogawa, M Alves… - Bone marrow …, 2019 - nature.com
Ocular graft-versus-host disease (GVHD) occurs in more than half of patients who develop
chronic GVHD after allogeneic hematopoietic cell transplantation (HCT), causing prolonged …
chronic GVHD after allogeneic hematopoietic cell transplantation (HCT), causing prolonged …
Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis
E Miserocchi, G Modorati, L Berchicci… - British Journal of …, 2016 - bjo.bmj.com
Background/aims To evaluate retrospectively the long-term efficacy of rituximab in patients
with severe juvenile idiopathic arthritis (JIA)-associated uveitis. Methods Eight patients (15 …
with severe juvenile idiopathic arthritis (JIA)-associated uveitis. Methods Eight patients (15 …
Photosensitizers and photodynamic therapy: Verteporfin
MB Parodi, C La Spina, L Berchicci… - Retinal …, 2016 - karger.com
Photodynamic therapy (PDT) is a phototherapy in which a photosensitive dye is injected into
a peripheral vein and activated by light in order to occlude choroidal vessels or change their …
a peripheral vein and activated by light in order to occlude choroidal vessels or change their …
Ocular chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in an Italian referral center
L Berchicci, A Rabiolo, A Marchese, L Iuliano… - The Ocular Surface, 2018 - Elsevier
Purpose This study aimed to assess the prevalence and clinical manifestations of ocular
graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation …
graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation …
[HTML][HTML] Conjunctival matrix metalloproteinase-9 clinical assessment in early ocular graft versus host disease
L Berchicci, E Aragona, A Arrigo, A Marchese… - Journal of …, 2021 - hindawi.com
Purpose. Graft versus Host Disease (GVHD) typically affects the ocular surface, with a
presentation resembling Dry Eye Disease (DED). Although the etiopathology is not …
presentation resembling Dry Eye Disease (DED). Although the etiopathology is not …
Retinal and choroidal changes of vitreoretinal lymphoma from active to remission phase after intravitreal rituximab
MV Cicinelli, A Marchese, E Miserocchi… - Ocular Immunology …, 2020 - Taylor & Francis
Purpose To identify main qualitative and quantitative changes by spectral-domain optical
coherence tomography (SD-OCT) in eyes with vitreoretinal lymphoma (VRL) shifting form …
coherence tomography (SD-OCT) in eyes with vitreoretinal lymphoma (VRL) shifting form …
Tear osmolarity in ocular graft-versus-host disease
L Berchicci, L Iuliano, E Miserocchi, F Bandello… - Cornea, 2014 - journals.lww.com
Purpose: The aim of this study was to evaluate tear osmolarity in patients with chronic graft-
versus-host disease (cGVHD) with ocular involvement. Methods: In this observational cross …
versus-host disease (cGVHD) with ocular involvement. Methods: In this observational cross …
Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center
L Berchicci, E Miserocchi, M Di Nicola… - European journal of …, 2014 - journals.sagepub.com
Purpose To evaluate demographic characteristics, clinical features, systemic disease
associations, visual outcomes, and treatment modalities of patients with episcleritis and …
associations, visual outcomes, and treatment modalities of patients with episcleritis and …
Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks
MB Parodi, P Iacono, C La Spina, L Berchicci… - American Journal of …, 2014 - Elsevier
Purpose To evaluate the effects of intravitreal bevacizumab injections in the treatment of
nonsubfoveal choroidal neovascularization (CNV) associated with angioid streaks. Design …
nonsubfoveal choroidal neovascularization (CNV) associated with angioid streaks. Design …
Ocular toxicity of mirvetuximab
E Corbelli, E Miserocchi, A Marchese, C Giuffrè… - Cornea, 2019 - journals.lww.com
Purpose: To report the clinical features and outcomes of corneal toxicity following
mirvetuximab soravtansine therapy. Methods: Five patients who were treated with …
mirvetuximab soravtansine therapy. Methods: Five patients who were treated with …